86 related articles for article (PubMed ID: 844789)
1. Alteration of plasma glucagon response to arginine after treatment in patients with diabetes mellitus, cushing's syndrome and hypothyroidism.
Seino Y; Goto Y; Kurahachi H; Sakurai H; Ikeda M
Horm Metab Res; 1977 Jan; 9(1):28-32. PubMed ID: 844789
[TBL] [Abstract][Full Text] [Related]
2. Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients.
Muller WA; Berger M; Suter P; Cüppers HJ; Reiter J; Wyss T; Berchtold P; Schmidt FH; Assal JP; Renold AE
J Clin Invest; 1979 May; 63(5):820-7. PubMed ID: 447830
[TBL] [Abstract][Full Text] [Related]
3. Possible role of alpha-cell insulin resistance in exaggerated glucagon responses to arginine in type 2 diabetes.
Tsuchiyama N; Takamura T; Ando H; Sakurai M; Shimizu A; Kato K; Kurita S; Kaneko S
Diabetes Care; 2007 Oct; 30(10):2583-7. PubMed ID: 17644622
[TBL] [Abstract][Full Text] [Related]
4. Glucagon response to arginine after treatment of diabetes mellitus.
Ohneda A; Ishii S; Horigome K; Yamagata S
Diabetes; 1975 Sep; 24(9):811-9. PubMed ID: 1158041
[TBL] [Abstract][Full Text] [Related]
5. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
6. Influence of metformin on arginine-induced glucagon secretion in human diabetes.
Carpentier J; Luyckx AS; Lefebvre PJ
Diabete Metab; 1975 Mar; 1():23-8. PubMed ID: 1234063
[TBL] [Abstract][Full Text] [Related]
7. Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol.
Jeffcoate WJ; Silverstone JT; Edwards CR; Besser GM
Q J Med; 1979 Jul; 48(191):465-72. PubMed ID: 542586
[TBL] [Abstract][Full Text] [Related]
8. [Raised glucagon levels of the blood induced by arginine: relation to blood sugar, blood insulin and STH in aged non-diabetics and diabetics].
Ferrero E; Casale G; Tassi G; Ciaponi A
Minerva Med; 1978 Apr; 69(18):1233-9. PubMed ID: 662151
[TBL] [Abstract][Full Text] [Related]
9. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
Hansen AP; Christensen SE; Lundbaek K
Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
[TBL] [Abstract][Full Text] [Related]
10. The effect of insulin treatment on the metabolic response to glucagon in diabetes.
Elkeles RS; Hambley J; Frost PG
Diabete Metab; 1977 Mar; 3(1):35-8. PubMed ID: 192610
[TBL] [Abstract][Full Text] [Related]
11. [Dynamics of the glucagon and C-peptide content in Itsenko-Cushing disease].
Arapova SD; Zavadskiĭ PS; Marova EI
Sov Med; 1980; (2):42-7. PubMed ID: 6987746
[No Abstract] [Full Text] [Related]
12. Insulin and glucagon response to glucose and arginine in two patients with "autoimmune" diabetes mellitus.
Del Prete GF; Tiengo A; Bersani G; Nosadini R; Garotti C; Trisotto A
Horm Metab Res; 1976 Mar; 8(2):149-50. PubMed ID: 1261966
[No Abstract] [Full Text] [Related]
13. Increase by somatostatin of the arginine induced rise in blood glucose in untreated insulin requiring diabetics.
Waldhäusl W; Bratusch-Marrain P; Nowotny P
Endokrinologie; 1979; 73(3):323-7. PubMed ID: 499100
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a sensitive and specific radioimmunoassay for pancreatic glucagon in human plasma and its clinical application.
Borghi VC; Wajchenberg BL; Albuquerque RH
Clin Chim Acta; 1984 Jan; 136(1):39-48. PubMed ID: 6692564
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
[TBL] [Abstract][Full Text] [Related]
16. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
Frier BM; Ashby JP; Nairn IM; Baird JD
Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620
[TBL] [Abstract][Full Text] [Related]
17. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
Luton JP; Molinie P; Strauch G; Guilhaume B; Bricaire H
Sem Hop; 1981 May 8-15; 57(17-18):841-9. PubMed ID: 6262921
[TBL] [Abstract][Full Text] [Related]
18. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
Giugliano D; Luyckx AS; Lefebvre PJ
Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
[TBL] [Abstract][Full Text] [Related]
19. Normalization of fasting hyperglucagonemia and excessive glucagon responses to intravenous arginine in human diabetes mellitus by prolonged infusion of insulin.
Gerich JE; Tsalikian E; Lorenzi M; Schneider V; Bohannon NV; Gustafson G; Karam JH
J Clin Endocrinol Metab; 1975 Dec; 41(06):1178-80. PubMed ID: 1206104
[TBL] [Abstract][Full Text] [Related]
20. Plasma insulin and glucagon responses to arginine in patients with thyroid dysfunction.
Seino Y; Goto Y; Taminato T; Ikeda M; Imura H
J Clin Endocrinol Metab; 1974 Jun; 38(6):1136-40. PubMed ID: 4831710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
